AI to detect hydroxychloroquine eye damage
Treatments studied
Part of Eyes & vision clinical trials.
This study uses artificial intelligence to look at eye images of people who have taken hydroxychloroquine for a long time. The goal is to better detect or predict early signs of retinal damage, so you can get the right care sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been taking hydroxychloroquine (a medicine for conditions like lupus or rheumatoid arthritis) for more than 10 years.
- You don't have other eye diseases that could look like hydroxychloroquine-related eye damage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special eye scans to look for early signs of damage in people who have been taking hydroxychloroquine for at least a year. It aims to help doctors monitor eye health more closely during treatment.
This trial tests a new type of eye test (ERG) to detect early damage from hydroxychloroquine, a drug used for conditions like lupus and rheumatoid arthritis. If you take hydroxychloroquine or have never taken it, you might help find better ways to protect your vision.
This study tests how well an AI system can diagnose retinal diseases from eye photos. It might help if you need a quick and accurate diagnosis using standard eye imaging.
This trial uses artificial intelligence to analyze eye images and help doctors diagnose eye diseases. It looks at images from routine care to train and test the AI system.
This trial uses artificial intelligence to help doctors make better decisions about eye disease. It analyzes your medical records and images to see how AI can improve care and track disease.
This study is testing an artificial intelligence tool that can automatically detect signs of glaucoma in photos of the retina. It may help confirm that the AI can accurately identify glaucoma, which could lead to faster diagnosis and monitoring for patients.
Hear when a new Hidroxicloroquine Intake trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.